vs

Side-by-side financial comparison of MACERICH CO (MAC) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

MACERICH CO is the larger business by last-quarter revenue ($261.7M vs $197.9M, roughly 1.3× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs -7.2%, a 13.9% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -4.4%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 12.0%).

The Macerich Company is a real estate investment trust that invests in shopping centers. It is the third-largest owner and operator of shopping centers in the United States. As of December 31, 2024, the company owned interests in 43 properties comprising 43 million square feet of leasable area. The company name is a portmanteau of its founders, Mace Siegel and Richard Cohen.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

MAC vs RGEN — Head-to-Head

Bigger by revenue
MAC
MAC
1.3× larger
MAC
$261.7M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+18.0% gap
RGEN
13.6%
-4.4%
MAC
Higher net margin
RGEN
RGEN
13.9% more per $
RGEN
6.7%
-7.2%
MAC
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
12.0%
MAC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MAC
MAC
RGEN
RGEN
Revenue
$261.7M
$197.9M
Net Profit
$-18.8M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
-7.2%
6.7%
Revenue YoY
-4.4%
13.6%
Net Profit YoY
91.1%
143.9%
EPS (diluted)
$-0.08
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MAC
MAC
RGEN
RGEN
Q4 25
$261.7M
$197.9M
Q3 25
$253.3M
$188.8M
Q2 25
$249.8M
$182.4M
Q1 25
$249.2M
$169.2M
Q4 24
$273.7M
$174.1M
Q3 24
$220.2M
$154.9M
Q2 24
$215.5M
$154.1M
Q1 24
$208.8M
$151.3M
Net Profit
MAC
MAC
RGEN
RGEN
Q4 25
$-18.8M
$13.3M
Q3 25
$-87.4M
$14.9M
Q2 25
$-40.9M
$14.9M
Q1 25
$-50.1M
$5.8M
Q4 24
$-211.2M
$-30.3M
Q3 24
$-108.2M
$-654.0K
Q2 24
$252.0M
$3.3M
Q1 24
$-126.7M
$2.1M
Gross Margin
MAC
MAC
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
MAC
MAC
RGEN
RGEN
Q4 25
9.0%
Q3 25
8.9%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
MAC
MAC
RGEN
RGEN
Q4 25
-7.2%
6.7%
Q3 25
-34.5%
7.9%
Q2 25
-16.4%
8.2%
Q1 25
-20.1%
3.4%
Q4 24
-77.2%
-17.4%
Q3 24
-49.1%
-0.4%
Q2 24
116.9%
2.2%
Q1 24
-60.7%
1.4%
EPS (diluted)
MAC
MAC
RGEN
RGEN
Q4 25
$-0.08
$0.24
Q3 25
$-0.34
$0.26
Q2 25
$-0.16
$0.26
Q1 25
$-0.20
$0.10
Q4 24
$-0.95
$-0.55
Q3 24
$-0.50
$-0.01
Q2 24
$1.16
$0.06
Q1 24
$-0.59
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MAC
MAC
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$280.2M
$767.6M
Total DebtLower is stronger
$5.1B
$542.2M
Stockholders' EquityBook value
$2.4B
$2.1B
Total Assets
$8.4B
$2.9B
Debt / EquityLower = less leverage
2.07×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MAC
MAC
RGEN
RGEN
Q4 25
$280.2M
$767.6M
Q3 25
$290.2M
$748.7M
Q2 25
$131.1M
$708.9M
Q1 25
$253.2M
$697.2M
Q4 24
$89.9M
$757.4M
Q3 24
$116.5M
$784.0M
Q2 24
$70.7M
$809.1M
Q1 24
$120.1M
$780.6M
Total Debt
MAC
MAC
RGEN
RGEN
Q4 25
$5.1B
$542.2M
Q3 25
$5.1B
$537.9M
Q2 25
$5.2B
Q1 25
$5.2B
Q4 24
$4.9B
$525.6M
Q3 24
$4.3B
Q2 24
$4.4B
Q1 24
$4.1B
Stockholders' Equity
MAC
MAC
RGEN
RGEN
Q4 25
$2.4B
$2.1B
Q3 25
$2.5B
$2.1B
Q2 25
$2.6B
$2.1B
Q1 25
$2.7B
$2.0B
Q4 24
$2.8B
$2.0B
Q3 24
$2.5B
$2.0B
Q2 24
$2.5B
$2.0B
Q1 24
$2.3B
$2.0B
Total Assets
MAC
MAC
RGEN
RGEN
Q4 25
$8.4B
$2.9B
Q3 25
$8.4B
$2.9B
Q2 25
$8.7B
$2.9B
Q1 25
$8.7B
$2.9B
Q4 24
$8.6B
$2.8B
Q3 24
$7.6B
$2.8B
Q2 24
$7.8B
$2.9B
Q1 24
$7.4B
$2.8B
Debt / Equity
MAC
MAC
RGEN
RGEN
Q4 25
2.07×
0.26×
Q3 25
2.02×
0.26×
Q2 25
2.02×
Q1 25
1.96×
Q4 24
1.78×
0.27×
Q3 24
1.73×
Q2 24
1.75×
Q1 24
1.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MAC
MAC
RGEN
RGEN
Operating Cash FlowLast quarter
$50.2M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MAC
MAC
RGEN
RGEN
Q4 25
$50.2M
$25.7M
Q3 25
$112.4M
$48.1M
Q2 25
$70.5M
$28.6M
Q1 25
$88.5M
$15.0M
Q4 24
$54.9M
$39.2M
Q3 24
$100.0M
$49.3M
Q2 24
$67.4M
$42.2M
Q1 24
$61.1M
$44.7M
Free Cash Flow
MAC
MAC
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
MAC
MAC
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
MAC
MAC
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
MAC
MAC
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
0.27×
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons